SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
Por:
de las Penas, R, Blasco, A, De Castro, J, Escobar, Y, Garcia-Campelo, R, Gurpide, A, Lopez-Lopez, R, Majem, M, Rodriguez, CA, Virizuela, JA
Publicada:
1 dic 2016
Resumen:
Chemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects of chemotherapy for cancer patients. It can cause severe discomfort and affect the quality of life. In recent years, the incorporation of new drugs has increased the efficacy of antiemetic treatments in the control of emesis associated with chemotherapy. This guideline, in which we give some treatment recommendations with level of evidence and grade of recommendation, provides an update of the previously published guideline of the Spanish Society of Medical Oncology and represents our continued commitment to improving supportive care in cancer patients.
Filiaciones:
de las Penas, R:
Consorcio Hosp Prov Castellon, Serv Oncol Med, Avda Dr Clara 19, Castellon De La Plana 12002, Castellon, Spain
Blasco, A:
Hosp Gen Univ Valencia, Serv Oncol Med, Valencia, Spain
De Castro, J:
Hosp Univ La Paz Madrid, Serv Oncol Med, Madrid, Spain
Escobar, Y:
Hosp Gen Univ Gregorio Maranon Madrid, Serv Oncol Med, Madrid, Spain
Garcia-Campelo, R:
Hosp Juan Canalejo, Complexo Hosp Univ A Coruna, Serv Oncol Med, La Coruna, Spain
Gurpide, A:
Clin Univ Navarra, Serv Oncol Med, Pamplona, Spain
Lopez-Lopez, R:
Complejo Hosp Univ Santiago de Compostela, Serv Oncol Med, Santiago De Compostela, Spain
Majem, M:
Hosp Santa Creu & St Pau Barcelona, Serv Oncol Med, Barcelona, Spain
Rodriguez, CA:
Hosp Univ Salamanca, Serv Oncol Med, Salamanca, Spain
Virizuela, JA:
Complejo Hosp Reg Virgen Macarena Sevilla, Serv Oncol Med, Seville, Spain
Green Published
|